We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRC icon
7876
SciSparc
SPRC
$3.95M
$19.3K ﹤0.01%
283
-82
-22% -$3.81K
DFEN icon
7877
Direxion Daily Aerospace & Defense Bull 3X ETF
DFEN
$445M
$19.2K ﹤0.01%
699
-767
-52% -$26.6K
SLND icon
7878
Southland Holdings
SLND
$36.9M
$19.2K ﹤0.01%
5,913
+1,109
+23% +$3.69K
STXD icon
7879
Strive 1000 Dividend Growth ETF
STXD
$66.1M
$19.2K ﹤0.01%
588
-2,733
-82% -$91.5K
IROHU
7880
DELISTED
Iron Horse Acquisitions Corp Unit
IROHU
$19.2K ﹤0.01%
+1,800
New +$19.3K
MKAM icon
7881
MKAM ETF
MKAM
$13.6M
$19.2K ﹤0.01%
656
-1
-0.2% -$29
STLN
7882
Starling Oncology Institute, Inc. Common Stock
STLN
$503M
$19.1K ﹤0.01%
+61,961
New +$16.1K
DEEF icon
7883
Xtrackers FTSE Developed ex US Multifactor ETF
DEEF
$56.2M
$19.1K ﹤0.01%
678
-10,834
-94% -$318K
JETD icon
7884
MAX Airlines -3x Inverse Leveraged ETN
JETD
$406K
$19.1K ﹤0.01%
+1,587
New +$22.2K
ONCY
7885
Oncolytics Biotech
ONCY
$95.1M
$19.1K ﹤0.01%
20,898
-2,038
-9% -$2.12K
CNAV
7886
Mohr Company Nav ETF
CNAV
$55M
$19.1K ﹤0.01%
+722
New +$19.2K
SER icon
7887
Serina Therapeutics
SER
$33.4M
$19.1K ﹤0.01%
3,809
+3,808
+380,800% +$22.5K
TBMC
7888
DELISTED
Trailblazer Merger Corp I
TBMC
$19.1K ﹤0.01%
1,717
+1,346
+363% +$14.9K
WORX
7889
DELISTED
SCWORX CORP NEW
WORX
$19.1K ﹤0.01%
752
+256
+52% +$5.62K
QQH icon
7890
HCM Defender 100 Index ETF
QQH
$756M
$19K ﹤0.01%
+284
New +$18.7K
OKUR
7891
OnKure Therapeutics
OKUR
$168M
$19K ﹤0.01%
2,213
+2,094
+1,760% +$31.7K
BOSC icon
7892
Better Online Solutions
BOSC
$31.7M
$19K ﹤0.01%
5,761
+4,427
+332% +$13.9K
VBIO
7893
Valion Bio
VBIO
$1.21M
$19K ﹤0.01%
3,224
-2,323
-42% -$10.8K
YJ
7894
Yunji
YJ
$6.3M
$18.9K ﹤0.01%
+11,752
New +$22K
PBL icon
7895
PGIM Portfolio Ballast ETF
PBL
$79.9M
$18.8K ﹤0.01%
669
+519
+346% +$15.6K
EYEG icon
7896
AB Corporate Bond ETF
EYEG
$27.8M
$18.8K ﹤0.01%
+537
New +$19.3K
HAWX icon
7897
iShares Currency Hedged MSCI ACWI ex US ETF
HAWX
$354M
$18.8K ﹤0.01%
583
+341
+141% +$11.2K
TBNK
7898
DELISTED
Territorial Bancorp Inc.
TBNK
$18.8K ﹤0.01%
1,929
+1,927
+96,350% +$20.3K
CORZW icon
7899
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.48B
$18.8K ﹤0.01%
+2,283
New +$20.6K
GQQQ
7900
Astoria US Quality Growth Kings ETF
GQQQ
$159M
$18.7K ﹤0.01%
+731
New +$18.8K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.